Leslie Parrette Acquires 340 Shares of Innospec (NASDAQ:IOSP) Stock

by · The Cerbat Gem

Innospec Inc. (NASDAQ:IOSP – Get Free Report) Director Leslie Parrette purchased 340 shares of the stock in a transaction that occurred on Friday, November 14th. The stock was bought at an average cost of $74.09 per share, for a total transaction of $25,190.60. Following the acquisition, the director directly owned 5,837 shares in the company, valued at $432,463.33. This trade represents a 6.19% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Innospec Stock Performance

NASDAQ:IOSP traded down $1.86 during trading hours on Monday, reaching $72.23. The stock had a trading volume of 233,455 shares, compared to its average volume of 201,213. The stock has a market cap of $1.79 billion, a P/E ratio of 92.60 and a beta of 1.06. The stock has a 50 day simple moving average of $76.80 and a 200 day simple moving average of $82.58. Innospec Inc. has a 12-month low of $71.06 and a 12-month high of $122.19.

Innospec (NASDAQ:IOSP – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The specialty chemicals company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.09. The firm had revenue of $441.90 million for the quarter, compared to analysts’ expectations of $443.00 million. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The business’s revenue for the quarter was down .3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.35 EPS. On average, equities analysts expect that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.

Innospec Announces Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Tuesday, November 18th will be given a dividend of $0.87 per share. This represents a yield of 237.0%. The ex-dividend date is Tuesday, November 18th. Innospec’s dividend payout ratio (DPR) is currently -5,800.00%.

Hedge Funds Weigh In On Innospec

A number of large investors have recently modified their holdings of IOSP. Wealth Enhancement Advisory Services LLC purchased a new stake in Innospec in the second quarter valued at approximately $345,000. American Century Companies Inc. increased its holdings in shares of Innospec by 27.7% in the 1st quarter. American Century Companies Inc. now owns 47,545 shares of the specialty chemicals company’s stock worth $4,505,000 after buying an additional 10,309 shares during the last quarter. Voya Investment Management LLC raised its position in shares of Innospec by 63.2% during the 1st quarter. Voya Investment Management LLC now owns 327,289 shares of the specialty chemicals company’s stock valued at $31,011,000 after buying an additional 126,750 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Innospec by 38.3% during the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock worth $57,000 after acquiring an additional 186 shares during the last quarter. Finally, Intech Investment Management LLC lifted its holdings in shares of Innospec by 30.7% during the 1st quarter. Intech Investment Management LLC now owns 22,023 shares of the specialty chemicals company’s stock worth $2,087,000 after acquiring an additional 5,178 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently issued reports on IOSP. Weiss Ratings lowered shares of Innospec from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Saturday, October 25th. Zacks Research downgraded shares of Innospec from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 4th. Finally, Wall Street Zen cut shares of Innospec from a “buy” rating to a “hold” rating in a report on Sunday, October 19th. One research analyst has rated the stock with a Strong Buy rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Innospec has a consensus rating of “Hold”.

View Our Latest Report on IOSP

Innospec Company Profile

(Get Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

See Also